A functional magnetic imaging (fMRI) study of the effects of cannabis-based medicines (CMEs) on the neutral activity associated with noxious thermal stimulation in healthy human volunteers (CRI.FM024). Protocol V2. FINAL

ISRCTN ISRCTN58754671
DOI https://doi.org/10.1186/ISRCTN58754671
Secondary identifying numbers N0176131698
Submission date
30/09/2004
Registration date
30/09/2004
Last edited
02/11/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Robert David Rogers
Scientific

Department of Psychiatry
University of Oxford
Warneford Hospital
Headington
Oxford
OX3 7JX
United Kingdom

Phone +44 (0)1865 226399
Email robert.rogers@psych.ox.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeOther
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titleA functional magnetic imaging (fMRI) study of the effects of cannabis-based medicines (CMEs) on the neutral activity associated with noxious thermal stimulation in healthy human volunteers (CRI.FM024). Protocol V2. FINAL
Study objectivesWe wish to undertake an experimental study of the effects of cannabis-based medicines (CMEs) on the neutral activity associated with the experience of pain in healthy volunteer participants. Fifteen volunteers will complete an fMRI scanning protocol on 4 separate study days on each of which they will receive one of 3 CMEs or a placebo treatment. During the scanning protocol, volunteers will receive noxious thermal stimulation on the dorsum of the left hand. Differences in volunteers' ratings of the intensity of the pain experience, as well as differences in measures of neutral activity associated with this experience, will provide important new information about CMEs' putative analgesia and their underlying mechanisms.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSign and Symptoms: Pain
Intervention15 volunteers will complete an fMRI scanning protocol on 4 separate study days on each of which they will receive one of 3 CMEs or a placebo treatment. During the scanning protocol, volunteers will receive noxious thermal stimulation on the dorsum of the left hand.
Intervention typeOther
Primary outcome measure1. Volunteers' rating of pain during noxious thermal stimulation
2. BOLD response associated with thermal stimulation after the 3 CMEs treatments and the placebo treatment sessions.
Secondary outcome measuresNot provided at time of registration
Overall study start date01/11/2003
Completion date31/10/2007

Eligibility

Participant type(s)Healthy volunteer
Age groupNot Specified
SexNot Specified
Target number of participants15 healthy people
Key inclusion criteriaNot provided at time of registration
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/11/2003
Date of final enrolment31/10/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

University of Oxford
Oxford
OX3 7JX
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Oxford Radcliffe Hospitals NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

02/11/2016: No publications found, verifying study status with principal investigator.